Similar articles

• Reteplase for clearance of occluded venous catheters.

  Owens L. Owens L. Am J Health Syst Pharm. 2002 Sep 1;59(17):1638-40. doi: 10.1093/ajhp/59.17.1638. Am J Health Syst Pharm. 2002. PMID: 12224345 No abstract available.
• Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial.

  Gittins NS, Hunter-Blair YL, Matthews JN, Coulthard MG. Gittins NS, et al. Arch Dis Child. 2007 Jun;92(6):499-501. doi: 10.1136/adc.2006.100065. Epub 2006 Oct 26. Arch Dis Child. 2007. PMID: 17068072 Free PMC article. Clinical Trial.
• Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.

  Jacobs BR, Haygood M, Hingl J. Jacobs BR, et al. J Pediatr. 2001 Oct;139(4):593-6. doi: 10.1067/mpd.2001.118195. J Pediatr. 2001. PMID: 11598611 Clinical Trial.
• Lytic therapy in central venous catheters for hemodialysis.

  McFarland HF, Dinwiddie L, Ferrell J, Forloines-Lynn S. McFarland HF, et al. Nephrol Nurs J. 2002 Aug;29(4):355-60; quiz 361-2. Nephrol Nurs J. 2002. PMID: 12224368 Review.
• The results of arterial thrombolysis.

  Kroese AJ, Staxrud LE. Kroese AJ, et al. Ann Chir Gynaecol. 1995;84(4):350-3. Ann Chir Gynaecol. 1995. PMID: 8687078 Review. No abstract available.